NCT00272311View on ClinicalTrials.gov

Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Cardiovascular DiseasesMetabolic Syndrome XAtherosclerosis
Interventions
DRUG

Aspirin

Dosage

Trial Locations (1)

21204

HeartDrug Research, LLC, Towson

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Florida Atlantic University

OTHER